A phase 2 study of HQK-1001, an oral fetal haemoglobin inducer, in β-thalassaemia intermedia.
about
Pharmacological Induction of Human Fetal Globin Gene in Hydroxyurea-Resistant Primary Adult Erythroid CellsNatural Remedies for the Treatment of Beta-Thalassemia and Sickle Cell Anemia-Current Status and Perspectives in Fetal Hemoglobin Reactivation.Evolution of hemoglobin loci and their regulatory elements.Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease.Orphan Drugs and Potential Novel Approaches for Therapies of β-Thalassemia: Current Status and Future Expectations
P2860
A phase 2 study of HQK-1001, an oral fetal haemoglobin inducer, in β-thalassaemia intermedia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
A phase 2 study of HQK-1001, a ...... in β-thalassaemia intermedia.
@en
A phase 2 study of HQK-1001, a ...... in β-thalassaemia intermedia.
@nl
type
label
A phase 2 study of HQK-1001, a ...... in β-thalassaemia intermedia.
@en
A phase 2 study of HQK-1001, a ...... in β-thalassaemia intermedia.
@nl
prefLabel
A phase 2 study of HQK-1001, a ...... in β-thalassaemia intermedia.
@en
A phase 2 study of HQK-1001, a ...... in β-thalassaemia intermedia.
@nl
P2093
P2860
P356
P1476
A phase 2 study of HQK-1001, a ...... , in β-thalassaemia intermedia
@en
P2093
Adlette Inati
Ali T Taher
David H K Chui
Hussein A Abbas
Mario Kahale
Susan P Perrine
Suzanne Koussa
Therese Abi Nasr
P2860
P304
P356
10.1111/BJH.12635
P407
P577
2013-11-13T00:00:00Z